5th Annual
Pulmonary Embolism Symposium: Register Now

October 4 - 5, 2019 / Renaissance Boston Waterfront Hotel

Register Now for the 5th Annual Pulmonary Embolism Symposium!

“Bringing it home to Boston”

Register for the 5th Annual Pulmonary Embolism Symposium!

This annual two day AMA PRA/ANCC-accredited conference entitled, Pulmonary Embolism: What is Known, and What We Need to Know:  A State of the Art and Scientific Update’, is designed for practicing clinicians who regularly care for patients with pulmonary embolism (PE), as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, medical and interventional management, novel treatment paradigms, and outcomes of PE.

Many would say that, when it comes to PE, we have an international crisis, given the prevalence of this disease, its enormous impact, and the relative lack of progress in its management. In fact, in 2008, the Surgeon General issued a “Call to Action” to improve the prevention, diagnosis and treatment of PE. Therefore, the purpose of this symposium is to improve the understanding of the pathophysiology, epidemiology, diagnosis, prevention and treatment of PE by educating our medical colleagues through a series of lectures and interactive discussions with thought leaders in the field.

An information-packed conference designed to:

  • To educate the medical community on the latest advances in the diagnosis, risk stratification and treatment of PE.
  • To explore the science behind PE diagnosis and treatment share knowledge regarding PE management.
  • To provide a forum for presentation of novel approaches to PE management, as they arise.
  • To recognize the potential complications from PE and how to prevent and treat them.
  • To highlight unique patient populations and their specific treatment challenges.
  • To promote and enhance coordinated, multidisciplinary care of PE patients.
  • To explore opportunities for quality improvement in PE management


Program Overview

Day 1: October 4th, 2019
6:30-7:45 AM
7:45-8:00 AM
Welcome and Opening Remarks
—Geno Merli, MD and Jerry Bartholomew, MD
8:00-8:45 AM

—Moderator: Victor Tapson, MD
Incidence, prevalence and impact of PE in the United States and the rest of the world. How many deaths are there?
—Stavros Konstantinides, MD
APEX/MARINER Trials. What have we learned?
—Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
Prevention of PE in the hospital. What are we doing and where are we going?
—Joseph A. Caprini, MD, MS, FACS, RVT, DFSVS
8:45-9:30 AM

—Moderator: Geoff Barnes, MD
The Pathobiology of thrombus formation. What is known in 2019
—Scott Cameron, MD
Pathophysiology of the right ventricle in acute pulmonary embolism
—Greg Piazza, MD
Pulmonary embolism risk factors. Rethinking provoked vs. unprovoked classifications
—James Douketis, MD
Natural history of pulmonary infarction
—Alison Witkin, MD
Questions and Answers
9:35-10:00 AM
Break / Visit Exhibits
10:00-11:00 AM

—Moderator: Christopher Kabrhel, MD
The importance of a thorough history and physical exam
—Parth Rali, MD
Which of the vital signs is most important for prognosis and why? Patients appearance, hypotension, tachycardia or blood pressure?
—Victor Tapson, MD
Pretest Probability Scores (Wells, Geneva, PERC rule) What about Clinical Gestalt?
—Phillip Wells, MD
How can we reduce over testing?
—Christopher Kabrhel, MD
Questions and Answers
11:00-11:20 AM
Patient Perspective with Martin Burvill - Interview and Audience Q&A
—Moderator: Michael Jaff, MD
11:20-1:00 PM
Lunch and Sponsored Satellite Sessions(Not for CME credit)
A Definitive Catheter-Based Solution for Pulmonary Embolism: Data, Experience, and Vision
—Moderator: Thomas M. Tu, MD
Sponsored by: Inari Medical, Inc.
Location: Atlantic Ballroom 2
Product Showcase presented by Pfizer/Bristol Myers Squibb
Sponsored by: Bristol-Myers Squibb and Pfizer alliance
Location: Atlantic Ballroom 1
EKOS Therapy for Intermediate High-Risk PE Patients
—Patrick J. Troy, MD
Sponsored by: Boston Scientific/BTG
Location: Pacific Ballroom ABC
1:00-2:00 PM

—Moderator: Rachel Rosovsky, MD
Which laboratory tests do I order? How to interpret a normal D-dimer in the setting of a high pretest probability score. What about age-adjusted D-dimers?
—Rachel Rosovsky, MD
CTA – are there false positives? What tumors might be mistaken for an acute PE? What do I do if the CTA is inconclusive?
—Brian Ghoshhajra, MD
Who should get a ventilation perfusion lung scan
—Sara Hegab, MD
In what settings? And what is the importance of the McConnell’s sign for prognosis?
—David Dudzinski, MD
How should lower extremity ultrasound be used in Acute PE for risk stratification?
—Ido Weinberg, MD
Questions and Answers
2:00-2:50 PM

—Moderator: Christina Fanola, MD
Which method(s) do I use for predicting 30 day mortality (PESI, sPESI, Bova score)
—Phillip Wells, MD
Biomarkers, echocardiogram or CT – Which one best predicts who is not going to do well?
—Christina Fanola, MD
Risk Stratification: How far do we need to go? Do we need every test?
—Mark Courtney, MD
Has PERT changed patient care?
—Pulkit Chaudhary , MD
Questions and Answers
2:50-3:10 PM
Break / Visit Exhibits
3:10-4:30 PM

—Moderator: Kenneth Rosenfield, MD
Should I start an acute pulmonary embolism patient on heparin, LMWH or a DOAC? Are there new anticoagulants in development?
—Scott Kaatz, MD
Systemic thrombolysis (full dose or 1/2 dose). What are the absolute and relative contraindications?
—Stavros Konstantinides, MD
Catheter directed thrombolysis —(Optalyse, Seattle, Ultima) which one should I use?
—Mike Rosenberg, MD
Percutaneous Thrombectomy - What are the available devices and their respective indication?
—Kenneth Rosenfield, MD
What are the current indications for ECMO and embolectomy?
—Ramin Malekan, MD
Adjunctive therapies -When should I place an IVC filter in the setting of an acute PE?
—John Moriarty, MD
Questions and Answers
4:40-5:40 PM
Breakout Session I
How to Form a PERT Team
—Moderators: Soophia Naydenov, MD and Rachel Rosovsky, MD
Everything you need to know to form a successful PERT team
—Christine Fanola, MD
Integrating PERT with clinical work, how do you get everyone to commit?
—Geoff Barnes, MD
What about competition for procedures between specialties?
—Sahil Parikh, MD
What about PERT burnout? What can you do to prevent it?
—James Horowitz, MD
Are there legal issues that confront a PERT team?
—Mitchell Weinberg, MD
Questions and Answers
Breakout Session II
Special Populations and the DOAC’s
—Moderators: Gregory Piazza, MD and Belinda Rivera-Lebron, MD
Obesity and the DOACS. What are the weight limits of these agents?
—Sam Schulman, MD
Drug interactions and the DOACs. How should they be managed?
—John Fanikos, MD
Renal impairment and the DOACs. Is there sufficient data to support their use?
—John Fanikos, MD
What is the latest data on DOACs for patients with HIT or the thrombophilia patient?
—Ken Bauer, MD
What is the incidence of DOAC failure and how should we manage it?
—Sam Schulman, MD
Questions and Answers
Breakout Session III
Pharmacomechanical Therapies in Depth
—Moderators: Jay Giri, MD and Charles Ross, MD
Ultrasound assisted thrombolysis. What are the advantages and disadvantages?
—Keith Sterling, MD
Mechanical thrombectomy - (Flow Triever, Penumbra, Angiovac). Which one should I use?
—Jim Benenati, MD
Heterogeneity in training opportunities and available operators for PE
—Jay Giri, MD
What I have needed to learn as an interventional cardiologist to become an effective PE interventionalist
—Andrew Klein, MD
What I have needed to learn as an interventional radiologist to become an effective PE interventionalist
—Akilesh Sista, MD
What I have needed to learn as a vascular/endovascular surgeon to become an effective PE interventionalist
—Charles Ross, MD
Questions and Answers
Breakout Session IV
How to Reverse Anticoagulation
—Moderator: Geroge A. Davis, PharmD, BCPS
Reversing DOACs in emergent and urgent situations: Latest Studies
—Adam T. Phillips, MD
How to operationalize using reversal agent for DOACs
—Geno Merli, MD
Management of bleeding secondary to the use of thrombolytic agents
—George Davis, MD
Should we have PERT like teams for anticoagulation reversal?
—Kristen Pogue, MD
Questions and Answers
5:45-6:30 PM
AHA Guidelines on PE
—Moderator: Jay Giri, MD
Panelists: Victor Tapson, MD; Kenneth Rosenfield, MD; Jana Montgomery, MD; Carin Gonsalves, MD; James Douketis, MD
6:30-8:30 PM
—Rachel Rosovsky, MD and Geroge A. Davis, PharmD, BCPS
Day 2: October 5th, 2019
6:30-6:45 AM
7:00-7:50 AM
International Panel
—Marc Carrier, MD, MSc, FRCPC, James Douketis, MD, FRCP(C), FACP, FCCP, Menno V. Huisman, MD, PhD, FESC, Frederikus A (Erik) Klok, MD PhD, NIE Shao-Ping (聂绍平), MD, PhD, FESC, FSCAI, Sam Schulman, MD, PhD, FRCPC, Philip Stephen Wells, MD, FRCP(C), MSc
7:45-8:00 AM
Welcome and Opening Remarks
—Geno Merli, MD and Jerry Bartholomew, MD
8:00-9:00 AM

—Moderator: Geno Merli, MD
Risk Scores to discharge patients home from the ER with an acute PE: Which one is best?
—Jeffrey Kline, MD
What is the risk of recurrent VTE according to baseline risk factors? (Surgery, trauma or minor trauma)
—Frederikus (Erik) Klok
What is the optimal duration of therapy? Which agent should I use? Include PADIS –PE
—James Douketis
Transition of care of a acute PE patient from the ED. What are the mechanics?
—Geno Merli, MD
Questions and Answers
9:00-10:00 AM

—Moderator: Ido Weinberg, MD
Who is responsible for following the PE patient post hospitalization?
—Menno Huisman, MD
When should I do thrombophilia testing? What about cancer screening?
—Marc Carrier, MD
Which patient needs a follow up ventilation/perfusion scan, echocardiogram or six-minute walk test? How do I decide who should be tested?
—Frederikus (Erik) Klok, MD
How long does it take to recover from an acute PE?
—Philip Wells, MD
Questions and Answers
10:00-10:30 AM
Break / Visit Exhibits
10:30-11:30 AM

—Moderator: Richard Channick, MD
How do I diagnose CTEPH? What are the clinical clues and risk factors. What tests do I order?
—Tim Morris, MD
What do we know about the CTEPH Prediction Scores: INPUT, OSIRIS, InShape-2
—Gustavo Heresi, MD
What are the medical treatment options for the CTEPH patient?
—Richard Channick, MD
Pulmonary embolectomy vs. Balloon Angioplasty? Which procedure for which patient?
—Bill Auger, MD
What are the post-pulmonary endarterectomy outcomes?
—Cam Wright, MD
Questions and Answers
11:30-12:00 PM
Sessions Most Interesting Paper
—Moderator: Belinda Rivera-Lebron, MD
Pert Consensus Statement
—Moderators: Belinda Rivera-Lebron, MD and Tim Morris, MD
12:00-1:30 PM
Lunch and Sponsored Satellite Sessions(Not for CME credit)
Advancing the Standard of Care for Patients: Key Knowledge Gaps in the Treatment of PE & DVT
—Moderators: Kenneth Rosenfield, MD and Akhilesh Sista, MD
Sponsored by: Thrombolex, Inc.
Location: Atlantic Ballroom 1
Evidence-Based Approach to Anticoagulation Therapy for DVT/PE
Sponsored by: Janssen Pharmaceuticals, Inc
Location: Platinum Ballroom ABC
1:30-2:30 PM
Breakout Session V
Pulmonary Embolism in the ER
—Moderator: Christopher Kabrhel, MD
What is the role of the Emergency physician in the PERT (team)?
—Mark Courtney, MD
What about Clinical Rules and the PROPER Trial in the ER?
—Jeffrey Kline, MD
What diagnostic strategies do I have in the ER when testing is not straightforward (elderly patients, renal failure, pregnant and unstable patients)?
—Emily Gundert, MD
What are the treatment options in the ER when time is critical?
—Aaron Weinberg, MD
What is the mortality of untreated pulmonary embolism in the ER?
—Darren Beam, MD
Breakout Session VI
Athletes and PE
—Moderator: Stephan Moll, MD
What is the etiology of sports related pulmonary embolism - predisposing factors, including thoracic outlet, popliteal venous and arterial syndrome and May-Thurner Syndrome
—Robert Schainfeld, MD
Contact vs. non contact sports. How to tell an athlete he or she may no longer participate in sports
—Stephan Moll, MD
How to manage the patient that wants to continue playing? Are there options?
—Jim Muntz, MD
Questions and Answers
Breakout Session VII
Air Travel And PE
—Moderator: David Slosky, MD
What is the incidence of air travel PE and who is at risk?
—David Slosky, MD
What can you tell your patient to do to prevent air travel PE?
—Jerry Bartholomew, MD
What to do if a PE develops in the air?
—Scott Cameron, MD
When can the patient fly again after sustaining a PE?
—Jana Montgomery, MD
Questions and Answers
Breakout Session VIII
Hemodynamic Support and Surgical Options
—Moderator: Oren Friedman, MD
What are indications for using the Impella RP
—Mahir Elder, MD
Mechanical circulatory support – when should it be used? VA ECMO, RV assist devices
—Michael Tong, MD
Bridging patients with ECMO - when should we use this?
—John Gurley, MD
Which patient is a candidate for suction thrombectomy?
—John Moriarty, MD
Which patient is a candidate for acute pulmonary embolectomy?
—Josh Goldberg, MD
Questions and Answers
2:30-3:30 PM
Workshop Session I
—Moderator: James Horowitz, MD
PE and Pregnancy – What are the anticoagulation and thrombolysis options?
—Menno Huisman, MD
Fat embolism, tumor emboli, amniotic fluid embolism – How do I differentiate these from a acute pulmonary embolism? What are the treatment options?
—Rachel Rosovsky, MD
What are treatment options for the acute trauma and post surgical PE patient?
—Carin Gonsalves, MD
What treatment options do we have for patients with a right atrial and/or left ventricle thrombus?
—Robert Maholic, MD and John Gurley, MD
Questions And Answers
Workshop Session II
—Moderators: Bill Auger, MD and Kenneth Rosenfield, MD
Which patient is a good candidate for performing balloon angioplasty? How many procedures are generally needed?
—Bill Auger, MD
What are the complications from BPA?
—Kenneth Rosenfield, MD
Who sets the standards for performing BPA? Which service should do the procedure? Interventional radiology or cardiology or surgery?
—Kenneth Rosenfield, MD
Is there a role for a multidisciplinary team in CTEPH management?
—Richard Channick, MD
Questions And Answers
Workshop Session III
—Moderator: Ihab Haddadin, MD
What are the indications for IVC filters in the acute PE patient?
—Joseph Campbell, MD
Bedside IVC filter placement – is it readily available and safe?
—Jon Matsumara, MD
What are complications of IVC Filters? Should all temporary IVC filters be retrieved?
—Collette Shaw, MD
What is the role for the Angel Catheter?
—Aaron Weinberg, MD
How to set up a IVC filter registry for your PERT team
—Brett Caroll, MD
Questions And Answers
Workshop Session IV
—Moderator: Victor Tapson, MD
Should each institution have a M&M for PERT Cases?
—Bahrat Awsare, MD
Who is monitoring the PERT outcomes at your institution?
—Mae West, MD
How do I assess the quality of my own PERT Program?
—Geoff Barnes, MD
Setting up a VTE prevention program for hospitalized patients
—Robert Eberhardt, MD
The PERT quality assurance registry-how will it change the future of PE management?
—Victor Tapson, MD
Questions And Answers
Workshop Session V
—Moderator: Tom Todoran, MD
Intubation technique(s) for the acute PE patient
—Susan Wilcox, MD
Bedside evaluation of the right ventricle
—Bret Carroll, MD
Bedside evaluation of the lower extremity
—Robert Schainfeld, MD
Bedside insertion of IVC filters
—Tom Todoran, MD
ECMO: outcomes and the changing paradigm in acute PE management
—Kenneth Rosenfield, MD
Questions And Answers
3:30-4:00 PM
—Geno Merli, MD and Jerry Bartholomew, MD


Stavros Konstantinides, MD, PhD, FESC
Professor, Center for Thrombosis and Hemostasis, Johannes Gutenberg University of Mainz Langenbeckstr, Germany
Mark Carrier, MD
Professor, Department of Medicine University of Ottawa, Vice-Chair of Research, Department of Medicine The Ottawa Hospital
James Douketis, MD
Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University
Menno Huisman, MD, PhD
Professor of Medicine, Department of Thrombosis and Hemostasis Leiden University Medical Center, Leiden, the Netherlands
Erik Klok, MD
Research Physician, Virchow Fellow, Leiden University Medical Centre
Sam Schulman, MD
Professor, Division of Hematology and Thromboembolism, Department of Medicine, McMaster University
Philip Wells, MD
Professor of Medicine, Chair and Chief of the Department of Medicine, The Ottawa Hospital and the University of Ottawa

Invited Faculty

Along with many distinguished faculty, below please find a few featured speakers:

Bill Auger, MDBharat Awsare, MD

Geoff Barnes, MD

Jerry Bartholomew, MD

Riyaz Bashir, MD, FACC, RVT

Darren Beam, MD, MS

Jim Benenati, MD-RASF

Scott Cameron, MD

Joseph Campbell, MD

Brett Caroll, MD

Marc Carrier, MD, FRCPC

Richard Channick, MD

Pulkit Chaudhary, MD

Mark Courtney, MD

George Davis, PharmD, BCPS

James Douketis, MD

David Dudzinski, MD

Robert Eberhardt, MD

Mahir Elder, MD

John Fanikos, MDChristina Fanola, MD

Oren Friedman, MD

Brian Ghoshhajra, MD, MBA

C. Michael Gibson, MS, MD

Jay Giri, MD, MPH

Joshua Goldberg, MD

Carin Gonsalves, MD

Emily Gundert, MD

Ihab Haddadin, MD

Sara Hegab, MD

Gustavo Heresi, MD

Jim Horowitz, MD

Menno Huisman, MD

Michael Jaff, MD

Scott Kaatz, MD

Chris Kabrhel, MD

Drew Klein, MD

Jeff Kline, MD

Erik Klok, MD, PhDStavros Konstantinides, MD

Belinda Rivera-Lebron, MD

Ramin Malekan, MD

Jon Matsumara, MD

Geno Merli, MD

Stephan Moll, MD

Jana Montgomery, MD

John Moriarty, MD, FACP

Tim Morris, MD

Jim Muntz, MD

Soophia Naydenov, MD, FCCP

Shao-Ping Nie, MD

Sahil Parikh, MD

Greg Piazza, MD, MS

Kristin Pogue, PharmD, BCPS

Kenny Rosenfield, MD

Rachel Rosovsky, MD

Charles Ross, MD

Robert Schainfeld, DOSam Schulman, MD

Colette Shaw, MD

Akilesh Sista, MD

David Slosky, MD

Alex Spyropoulos, MD, FACP, FCCP, FRCPC

Keith Sterling, MD

Vic Tapson, MD

Tom Todoran, MD

Michael Tong, MD

Aaron Weinberg, MD

Ido Weinberg, MD

Mitchell Weinberg, MD

Phillip Wells, MD, MSc, FRCPC

Mae West, MD

Susan Wilcox, MD

Alison Witkin, MD

Cam Wright, MD


The Reinassance Waterfront Hotel
 606 Congress St
Boston, MA 02210

Click Here to make a reservation.